Autosomal Dominant Alzheimer''s Disease: A Pathophysiology Review
★★★★★
★★★★★
English
Biomarkers play an indispensable role in Alzheimer's Disease (AD) diagnosis, clinical research and clinical trials. Our understanding of AD biomarkers has been profoundly impacted by the study of Autosomal Dominant Alzheimer's Disease (ADAD). Though memory loss is the most common feature of ADAD, motor dysfunction, neuropsychiatric symptoms, and epileptiform abnormalities are present at a much higher rate in ADAD than sporadic, late-onset AD. There are over 250 known ADAD-causative variants in PSEN1, 2, and APP. This genetic heterogeneity is reflective in both biomarkers and cognitive heterogeneity across people with ADAD. Autosomal Dominant Alzheimer's Disease: A Pathophysiology Review discusses the history of ADAD and its cognitive, neuroimaging and biomarker trajectories. This book focuses how ADAD can provide a unique insight into genetically driven and sporadic forms of AD. Edited by Dr. Jasmeer Chhatwal and Dr. Eric McDade, and contributed by leading experts in the field, this book will be become the leading tool for researchers and clinicians in Alzheimer's Disease.
See more
Current price
€118.67
Original price
€128.99
Save 8%
Will deliver when available. Publication date 01 Sep 2024
Product Details
Dimensions: 151 x 229mm
Publication Date: 01 Sep 2024
Publisher: Elsevier Science & Technology
Publication City/Country: United Kingdom
Language: English
ISBN13: 9780323997164
About
Jasmeer Chhatwal MD PhD MMSc Assistant Professor of Neurology Harvard Medical School; Associate Neurologist Massachusetts General Hospital. Dr. Chhatwal is a neurologist and translational neuroscientist at Harvard Medical School who uses a diverse array of genetic neuroimaging and biochemical tools to study Alzheimers disease. He serves as a site leader for the Dominantly Inherited Alzheimers Network (DIAN) a project leader for the Harvard Aging Brain Study and leads studies examining potentially modifiable risk factors for cognitive decline in older adults. Clinically he sees a wide variety of patients with cognitive disorders with a particular focus on early onset Alzheimer's disease (AD). Eric McDade DO Associate Professor of Neurology Washington University School of Medicine at St. Louis. Dr. McDade is a Neurologist with a specialty in Cognitive Neurology. He is the Associate Director of the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) and the Clinical Core lead of the Dominantly Inherited Alzheimer Network. Dr. McDades clinical research focuses on fluid and imaging biomarkers in preclinical Alzheimer disease and their application in the development of Alzheimer prevention clinical trials. He leads the DIAN-TU Primary Prevention Trial.